MAPK3 and glioblastoma: EGFR activates ERK1/2-dependant nuclear translocation of PKM2 and activates Myc, which in turn up-regulate GLUT1, LDHA and PKM2 expression in human glioblastoma multiforme (GBM) cells [41].